INSTITUTO DE BIOMEDICINA Y GENÉTICA MOLECULAR (IBGM)
Instituto
Hospital Arnau de Vilanova
Valencia, EspañaPublicaciones en colaboración con investigadores/as de Hospital Arnau de Vilanova (9)
2023
-
Effect of viral storm in patients admitted to intensive care units with severe COVID-19 in Spain: a multicentre, prospective, cohort study
The Lancet Microbe, Vol. 4, Núm. 6, pp. e431-e441
2022
-
N-antigenemia detection by a rapid lateral flow test predicts 90-day mortality in COVID-19: A prospective cohort study
Clinical Microbiology and Infection, Vol. 28, Núm. 10, pp. 1391.e1-1391.e5
-
Proprotein convertase subtilisin/kexin type 9 inhibitors in secondary prevention of vascular events in patients with stroke: Consensus document and practice guidance
Neurologia, Vol. 37, Núm. 2, pp. 136-150
2021
-
Circulating microRNA profiles predict the severity of COVID-19 in hospitalized patients
Translational Research, Vol. 236, pp. 147-159
-
Use of cardiovascular polypills for the secondary prevention of cerebrovascular disease
Neurologia, Vol. 36, Núm. 1, pp. 1-8
2019
-
The Neuronal Ischemic Tolerance Is Conditioned by the Tp53 Arg72Pro Polymorphism
Translational Stroke Research, Vol. 10, Núm. 2, pp. 204-215
2016
-
Molecularly determined total tumour load in lymph nodes of stage I–II colon cancer patients correlates with high-risk factors. A multicentre prospective study
Virchows Archiv, Vol. 469, Núm. 4, pp. 385-394
-
The effect of supplemental oxygen in obesity hypoventilation syndrome
Journal of Clinical Sleep Medicine, Vol. 12, Núm. 10, pp. 1379-1388
2014
-
Análisis de recursos asistenciales para el ictus en España en 2012: ¿beneficios de la Estrategia del Ictus del Sistema Nacional de Salud?
Neurologia, Vol. 29, Núm. 7, pp. 387-396